Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in VERU — Veru Inc.

CIK 19617 NEW YORK, NY
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,166
-$418 QoQ
Shares Held
373
-48.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 20% Shared 0% None 80%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. VERU ranks #364 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,166 373
2026-03-31 $1,584 717
2025-12-31 $719 336
2025-09-30 $2,036 536
2025-06-30 $1,423 2,455
2025-03-31 $30,962 63,190
2024-12-31 $166,257 255,782
2024-09-30 $45,025 58,475
2024-06-30 $47,363 56,386
2024-03-31 $63 91
2023-12-31 $65 91
2023-09-30 $65 91
2023-06-30 $108 91
2023-03-31 $296,089 255,250
2022-12-31 $512,212 97,010
2022-09-30 $1,018,481 88,410
2022-06-30 $896,111 79,302
2022-03-31 $348,096 72,070
2021-12-31 $551,550 93,642
2021-09-30 $501,707 58,817
2021-06-30 $1,115,264 138,199
2021-03-31 $1,733,185 160,778
2020-12-31 $1,165,915 134,788
2020-09-30 $86,630 33,065
2020-06-30 $134,635 40,310
2020-03-31 $85,562 26,166